Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aging2.0 is a global innovation platform and network dedicated to accelerating breakthroughs in the aging and senior care sectors. Founded in 2012, the organization connects entrepreneurs, investors, and industry leaders to address the challenges and opportunities of an aging population. It operates through a decentralized model with volunteer-led chapters in dozens of cities worldwide, hosting events and providing resources for 'age-tech' startups. The company focuses on eight 'Grand Challenges' ranging from brain health to caregiving and financial wellness. In 2022, Aging2.0 was acquired by LoveToKnow Media to further integrate its community-driven insights into a broader digital media portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aging2.0.